Product Description: Cytembena is inhibitor for replicative DNA synthesis, purine synthesis and tetrahydrofolate formylase activity. Cytembena ameliorates ovarian or breast cancer, relieves the pain from skeletal metastases[1][2].
Formula: C11H8BrNaO4
References: [1]Falkson HC, et al., Phase II trial of cytembena in patients with advanced ovarian and breast cancer. Cancer Treat Rep. 1976 Nov;60(11):1655-8./[2]Berger NA, et al., Description of a permeable eukaryotic cell system to study agents affecting DNA synthesis: demonstration that cytembena is a direct inhibitor of replicative DNA synthesis. J Natl Cancer Inst. 1977 Apr;58(4):1167-9.
CAS Number: 21739-91-3
Molecular Weight: 307.07
Compound Purity: 99.53
Research Area: Cancer
Solubility: DMSO : 50 mg/mL (ultrasonic)
Target: DNA/RNA Synthesis